Task: Answer the multiple-choice question.
Question: Which drug exhibits a 4.372\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CSc1nc(C(=O)N2CCCC(Nc3ccc(C)c(C)c3)C2)cs1
(b) CC(C)(CC(=O)O)CC(=O)N1CCN(c2cc(C(F)(F)F)nc3ccccc23)CC1
Answer: a. CSc1nc(C(=O)N2CCCC(Nc3ccc(C)c(C)c3)C2)cs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1nc(C(=O)N2CCCC(Nc3ccc(C)c(C)c3)C2)cs1
CSc1nc(C(=O)N2CCCC(Nc3ccc(C)c(C)c3)C2)cs1
[3-(3,4-dimethylanilino)piperidin-1-yl]-(2-methylsulfanyl-1,3-thiazol-4-yl)methanone